Research Topic · Peer-Reviewed

Follicular Thyroid Cancer

Follicular Thyroid Cancer is the second most common form of differentiated thyroid carcinoma, arising from the follicular epithelial cells that produce thyroid hormone. It is distinguished from the more frequent papillary type by its tendency to invade blood vessels and spread haematogenously, with metastases reachi…

Curated from this journal's research 📚 8 peer-reviewed articles cited Cited 19× across the literature 🔖 ISSN 2574-4496 🗓 Reviewed July 2026

Overview

Follicular Thyroid Cancer is the second most common form of differentiated thyroid carcinoma, arising from the follicular epithelial cells that produce thyroid hormone. It is distinguished from the more frequent papillary type by its tendency to invade blood vessels and spread haematogenously, with metastases reaching distant sites such as bone and lung, rather than spreading predominantly through lymphatic channels. A defining diagnostic feature is that malignancy is established by demonstrating capsular or vascular invasion on histological examination of the resected tumour, which is why fine-needle aspiration cytology alone often cannot reliably separate follicular carcinoma from benign follicular adenoma. As a well-differentiated cancer, it generally retains features of normal follicular cells, including iodine avidity, which underpins its responsiveness to radioactive iodine. Management of differentiated Thyroid Cancer typically combines surgical resection, frequently total thyroidectomy, with radioactive iodine therapy for selected patients and subsequent thyroid hormone suppression and long-term surveillance, an approach reflected in studies of treatment outcomes over extended follow-up. Molecular diagnostic methods increasingly assist in clinical assessment and risk stratification, and trace-element analyses of thyroid nodules have been explored to help distinguish malignant from benign tissue. Although follicular Thyroid Cancer can behave aggressively when widely invasive, well-differentiated disease often carries a favourable prognosis with appropriate surgical and adjuvant treatment, making accurate diagnosis and staging central to its management.

Research published in this journal

8 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 8 articles above have been cited 19 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Follicular Thyroid Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Thyroid Cancer (ISSN 2574-4496).

Journal editorial board
Giovanni Mauri · Italy Pamela Pinzani · Italy Byeong-Cheol Ahn · South Korea

This page summarises published research for orientation; it is not medical or professional advice.